We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model.
- Authors
Inoue, Hiroyuki; Iga, Mutsunori; Meng Xin; Asahi, Saori; Nakamura, Takafumi; Kurita, Ryo; Nakayama, Masaharu; Nakazaki, Yukoh; Takayama, Koichi; Nakanishi, Yoichi; Tani, Kenzaburo
- Abstract
Transduction of the granulocyte-macrophage colony stimulating factor (GM-CSF) gene into mouse tumor cells abrogates their tumorigenicity in vivo. Our previous report demonstrated that gene transduction of GM-CSF with either TARC or RANTES chemokines suppressed in vivo tumor formation. In this paper, we examined whether the addition of either recombinant TARC or RANTES proteins to irradiated GM-CSF-transduced tumor vaccine cells enhanced antitumor immunity against established mouse tumor models to examine its future clinical application. Three million irradiated WEHI3B cells retrovirally transduced with murine GM-CSF cDNA in combination with either recombinant TARC or RANTES were subcutaneously inoculated into syngeneic WEHI3B-preestablished BALB/c mice. Vaccinations were well tolerated. Mice treated with GM-CSF-transduced cells and the chemokines demonstrated significantly longer survival than mice treated with GM-CSF-transduced cells alone. Splenocytes harvested from mice treated with the former vaccines produced higher levels of IL-4, IL-6, IFN-γ, and TNF-α, suggesting enhanced innate and adaptive immunity. Immunohistochemical analysis of tumor sections after vaccination revealed a more significant contribution of CD4+ and CD8+ T cells to tumor repression in the combined vaccine groups than controls. TARC and RANTES enhance the immunological antitumor effect induced by GM-CSF in mouse WEHI3B tumor models and may be clinically useful.
- Subjects
GRANULOCYTE-macrophage colony-stimulating factor; GENETIC transduction; VACCINATION; IMMUNITY; IMMUNOLOGY; LABORATORY mice
- Publication
Cancer Immunology, Immunotherapy, 2008, Vol 57, Issue 9, p1399
- ISSN
0340-7004
- Publication type
Article
- DOI
10.1007/s00262-008-0476-7